Praxis Precision Medicines I Earnings

Praxis Precision Medicines I’s revenue fell -100% since last year same period to $0Mn in the Q4 2025. On a quarterly growth basis, Praxis Precision Medicines I has generated NaN% jump in its revenue since last 3-months.

Praxis Precision Medicines I’s net profit fell -51.52% since last year same period to $-88.91Mn in the Q4 2025. On a quarterly growth basis, Praxis Precision Medicines I has generated -20.26% fall in its net profits since last 3-months.

Praxis Precision Medicines I’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2025. On a quarterly growth basis, Praxis Precision Medicines I has generated NaN% jump in its net profit margins since last 3-months.

Praxis Precision Medicines I’s earning per share (EPS) estimates for the current quarter stand at -3.37 - a 2.88% jump from last quarter’s estimates.

Praxis Precision Medicines I’s earning per share (EPS) estimates for the current year stand at -3.37.

Praxis Precision Medicines I’s earning per share (EPS) fell -19.05% since last year same period to -3.5 in the Q4 2025. This indicates that the Praxis Precision Medicines I has generated -19.05% annual rate of fall in its earning per share (EPS) in the last 4 quarters.